Download PDF
1
/
Pages
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Pneumocystis jirovecii in immunocompromised patients with rheumatic diseases
Paloma Vela Casasempere; Paloma Ruiz Torregrosa; Raquel García Sevila;
Reumatol Clin. 2021;17:290-6
Recommendations by the Spanish Society of Rheumatology on risk management of biological treatment and JAK inhibitors in patients with rheumatoid arthritis
Alejandro Balsa; Petra Díaz del Campo Fontecha; Lucía Silva Fernández; José Valencia Martín; Virginia Nistal Martínez; Fernando León Vázquez; M. Vanesa Hernández Hernández; Héctor Corominas; Rafael Cáliz Cáliz; José María Aguado García; Gloria Candelas Rodríguez; Nora Ibargoyen Roteta; Arturo Martí Carvajal; M. Nieves Plana Farras; Janet Puñal Riobóo; Hye Sang Park; Yolanda Triñanes Pego; Virginia Villaverde García;
Reumatol Clin. 2023;19:533-48
Reply to the Letter to the Editor from Drs Suárez-Diaz and Caminal-Montero in reference to the special article ¿Recommendations for prevention of infection in systemic autoimmune rheumatic diseases¿
Íñigo Rúa-Figueroa Fernández de Larrinoa; Patricia Carreira Delgado; Noé Brito García; Beatriz Tejera Segura; Julián de la Torre Cisneros;
Reumatol Clin. 2023;19:173